Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, 1:1, non-comparative phase II trial. Patients with early
stage MPM will be randomized between Arm A: immediate P/D followed by three cycles of
chemotherapy (pemetrexed 500mg/m2 and cisplatin 75 mg/m2, both drugs given on day 1, every
three weeks) Arm B: three cycles of chemotherapy (same regimen) followed by P/D, for
non-progressing patients
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC